Clinical Research Directory
Browse clinical research sites, groups, and studies.
Feasibility Study of Uterine Transplantation From Living Donors in Terms of Efficacy and Safety in Patients With Mayer-Rokitansky-Küster-Hauser Syndrome (MRKH)
Sponsor: Hopital Foch
Summary
In France, one in 4500 women is affected by the MayerRokitantskyKüsterHauser (MRKH) syndrome which is characterized by the absence of uterus at birth. Currently, the only solutions for these patients are: * Gestational surrogacy, prohibited in France * Adoption * Resignation Uterine transplantation could become a good alternative. This study is conducted in 10 patients with MRKH type I syndrome, who will be transplanted from a living donor uterus
Key Details
Gender
FEMALE
Age Range
18 Years - 65 Years
Study Type
INTERVENTIONAL
Enrollment
20
Start Date
2017-12-14
Completion Date
2034-12-14
Last Updated
2025-03-07
Healthy Volunteers
Yes
Conditions
Interventions
Uterine transplantation
Uterine transplantation from living donor
Locations (1)
Hopital Foch
Suresnes, France